173 related articles for article (PubMed ID: 25558642)
1. The expression of EGFR, cerbB2, p16, and p53 and their relationship with conventional parameters in squamous cell carcinoma of the larynx.
Şimşek H; Han Ü; Önal B; Şimişek G
Turk J Med Sci; 2014; 44(3):411-6. PubMed ID: 25558642
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
Nijkamp MM; Span PN; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende PL; de Jong M; van der Kogel AJ; Bussink J; Kaanders JH
Eur J Cancer; 2013 Oct; 49(15):3202-9. PubMed ID: 23867129
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
[TBL] [Abstract][Full Text] [Related]
5. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C
Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107
[TBL] [Abstract][Full Text] [Related]
6. Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
Owusu-Afriyie O; Owiredu WKBA; Owusu-Danquah K; Komarck C; Foltin SK; Larsen-Reindorf R; Acheampong E; Quayson SE; Prince MEP; McHugh JB; Donkor P; Merajver SD; Brenner JC
PLoS One; 2018; 13(8):e0202790. PubMed ID: 30138436
[TBL] [Abstract][Full Text] [Related]
7. [Relation between epidermal growth factor receptor (EGFR) and p53 expression and radiocurability of laryngeal squamous cell cancer].
Dupla D; Fraczek M; Woźniak Z; Krecicki T
Otolaryngol Pol; 2009; 63(3):249-55. PubMed ID: 19886531
[TBL] [Abstract][Full Text] [Related]
8. PDGFRα/HER2 and PDGFRα/p53 Co-expression in Oral Squamous Cell Carcinoma.
Cierpikowski P; Lis-Nawara A; Gajdzis P; Bar J
Anticancer Res; 2018 Feb; 38(2):795-802. PubMed ID: 29374704
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression patterns of the HER4 receptors in normal mucosa and in laryngeal squamous cell carcinomas: antioncogenic significance of the HER4 protein in laryngeal squamous cell carcinoma.
Bussu F; Ranelletti FO; Gessi M; Graziani C; Lanza P; Lauriola L; Paludetti G; Almadori G
Laryngoscope; 2012 Aug; 122(8):1724-33. PubMed ID: 22549618
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of phosphated signal transducer and activator of transcription 3 and p53 protein in laryngeal squamous cell carcinoma].
Dai L; Liu T; Zhou X; Wei Q; Li Y; Cui C; Li M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Sep; 27(18):991-4. PubMed ID: 24459924
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma.
Kontić M; Milovanović J; Čolović Z; Poljak NK; Šundov Ž; Sučić A; Pešutić-Pisac V
Eur Arch Otorhinolaryngol; 2015 Feb; 272(2):401-5. PubMed ID: 25294054
[TBL] [Abstract][Full Text] [Related]
12. [Expression of cyclooxygenase-2 and p53 and their correlation in carcinoma of larynx].
Lu H; Gong S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):421-3. PubMed ID: 15499987
[TBL] [Abstract][Full Text] [Related]
13. Differential biomarker expression in head and neck cancer correlates with anatomical localization.
Tamás L; Szentkúti G; Eros M; Dános K; Brauswetter D; Szende B; Zsákovics I; Krenács T
Pathol Oncol Res; 2011 Sep; 17(3):721-7. PubMed ID: 21487776
[TBL] [Abstract][Full Text] [Related]
14. Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma.
Husain H; Psyrri A; Markovic A; Rampias T; Pectasides E; Wang H; Slebos R; Yarbrough WG; Burtness B; Chung CH
Laryngoscope; 2012 Dec; 122(12):2762-8. PubMed ID: 23086695
[TBL] [Abstract][Full Text] [Related]
15. p16 and p53 expression status in head and neck squamous cell carcinoma: a correlation with histological, histoprognostic and clinical parameters.
Karpathiou G; Monaya A; Forest F; Froudarakis M; Casteillo F; Marc Dumollard J; Prades JM; Peoc'h M
Pathology; 2016 Jun; 48(4):341-8. PubMed ID: 27113547
[TBL] [Abstract][Full Text] [Related]
16. ADC-histogram analysis in head and neck squamous cell carcinoma. Associations with different histopathological features including expression of EGFR, VEGF, HIF-1α, Her 2 and p53. A preliminary study.
Meyer HJ; Leifels L; Hamerla G; Höhn AK; Surov A
Magn Reson Imaging; 2018 Dec; 54():214-217. PubMed ID: 30189236
[TBL] [Abstract][Full Text] [Related]
17. Epidermal Growth Factor Receptor (EGFR) and Keratin 5 (K5): Versatile Keyplayers Defining Prognostic and Therapeutic Sub-classes of Head and Neck Squamous Cell Carcinomas.
Cimpean AM; Balica RA; Doros IC; Balica NC; Gaje PN; Popovici RA; Raica M
Cancer Genomics Proteomics; 2016; 13(1):75-81. PubMed ID: 26708602
[TBL] [Abstract][Full Text] [Related]
18. The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors.
Khademi B; Shirazi FM; Vasei M; Doroudchi M; Gandomi B; Modjtahedi H; Pezeshki AM; Ghaderi A
Cancer Lett; 2002 Oct; 184(2):223-30. PubMed ID: 12127695
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck.
Watson RF; Chernock RD; Zhang KH; Michel LS; Adkins DR; El-Mofty SK; Lewis JS
Head Neck Pathol; 2015 Sep; 9(3):360-8. PubMed ID: 25563452
[TBL] [Abstract][Full Text] [Related]
20. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
